Results 291 to 300 of about 177,876 (307)
Some of the next articles are maybe not open access.

Association Between Specimen Length and Number of Sections and Diagnostic Yield of Temporal Artery Biopsy for Giant Cell Arteritis

Arthritis care & research, 2020
To investigate the association between specimen length and number of sections evaluated and the diagnostic yield of temporal artery biopsy (TAB) for giant cell arteritis (GCA).
F. Muratore   +10 more
semanticscholar   +1 more source

Increased rather than decreased incidence of giant-cell arteritis during the COVID-19 pandemic

Annals of the Rheumatic Diseases, 2020
We read with much interest the article entitled “Impact of delayed diagnoses at the time of COVID-19: increased rate of preventable bilateral blindness in giant cell arteritis”,1 reporting a reduction in the requests for fast-track assessment of giant ...
A. Lecler   +3 more
semanticscholar   +1 more source

Cranial and large vessel activity on positron emission tomography scan at diagnosis and 6 months in giant cell arteritis

International Journal of Rheumatic Diseases, 2020
Positron emission tomography/computed tomography (PET/CT) can detect cranial and large vessel inflammation in giant cell arteritis (GCA). We aimed to determine the change and significance of vascular activity at diagnosis and 6 months.
A. Sammel   +10 more
semanticscholar   +1 more source

Diagnostic Accuracy of Positron Emission Tomography/Computed Tomography of the Head, Neck, and Chest for Giant Cell Arteritis: A Prospective, Double‐Blind, Cross‐Sectional Study

Arthritis & Rheumatology, 2019
Positron emission tomography/computed tomography (PET/CT) has not been well studied as a first‐line test for giant cell arteritis (GCA), due, in part, to historical limitations in visualizing the cranial arteries.
A. Sammel   +12 more
semanticscholar   +1 more source

Giant cell arteritis

Current Treatment Options in Neurology, 2004
Patients with a suspected diagnosis of giant cell arteritis (GCA) should be started on high-dose corticosteroid therapy without delay. A temporal artery biopsy should be performed after initiation of therapy to confirm the diagnosis. Patients with acute visual or neurologic symptoms present a neuro-ophthalmic emergency.
Laura J. Balcer, Jennifer K Hall
openaire   +3 more sources

Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.

Journal of the American Medical Association (JAMA), 2016
IMPORTANCE Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are related inflammatory disorders occurring in persons aged 50 years and older. Diagnostic and therapeutic approaches are heterogeneous in clinical practice. OBJECTIVE To summarize
F. Buttgereit   +3 more
semanticscholar   +1 more source

Giant cell arteritis

Lupus, 1998
In many populations giant cell arteritis (GCA) is the most common form of vasculitis. Genetic markers, ethnic factors, and increasing age over 50 years appear to enhance susceptibility and an infection may trigger its onset. Recent investigations provide evidence that the vasculitic reaction is part of an immune response to an antigen residing in ...
openaire   +3 more sources

Giant cell arteritis

Current Treatment Options in Neurology, 1999
Diagnosis and management of giant cell (temporal) arteritis (GCA) should be performed by physicians who can accurately monitor the ophthalmologic, neurologic, and systemic sequelae of the disease as well as the numerous side effects of systemic corticosteroids, which are typically necessary for treatment.
Roger E. Turbin, Mark J. Kupersmith
openaire   +3 more sources

Factors Associated with Relapse and Dependence on Glucocorticoids in Giant Cell Arteritis

Journal of Rheumatology, 2019
Objective. To identify characteristics and factors associated with relapse and glucocorticoid (GC) dependence in patients with giant cell arteritis (GCA). Methods.
A. Dumont   +9 more
semanticscholar   +1 more source

Giant cell arteritis

Journal of Clinical Neuroscience, 2009
Giant cell arteritis (GCA) is an immune-mediated vasculitis affecting individuals over 50 years of age. It is characterised by granulomatous inflammation that affects medium-sized and large arteries. The wide spectrum of clinical manifestations can be divided into those related to tissue ischemia from vascular lesions and those related to a systemic ...
Helen V Danesh-Meyer   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy